세계의 신경학용 AI 시장

The global market for AI in neurology was valued at $563.6 million in 2024 and is estimated to increase from $705.6 million in 2025 to reach $2.5 billion by 2030, at a compound annual growth rate (CAGR) of 28.9% from 2025 through 2030.

The North American market for AI in neurology was valued at $266.1 million in 2024 and is estimated to increase from $343.6 million in 2025 to reach $1.4 billion by 2030, at a CAGR of 32.6% from 2025 through 2030.

The Asia-Pacific market for AI in neurology was valued at $84.5 million in 2024 and is estimated to increase from $106.5 million in 2025 to reach $391.3 million by 2030, at a CAGR of 29.7% from 2025 through 2030.

Report Scope

The report provides an overview of the global market for AI in neurology and analyzes market trends. It includes global revenue (in $ millions) with 2024 as the base year, estimated data for 2025, and projections from 2026 to 2030. The market is segmented based on type, end-user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America, focusing on major countries in these regions.

The report provides an in-depth analysis of the global AI in neurology market, emphasizing the major driving forces and emerging technologies shaping this evolving field. It explores how artificial intelligence (AI) transforms neurology through enhanced diagnostic capabilities, early disease detection, personalized treatment planning and remote patient monitoring for neurological conditions such as Alzheimer's, Parkinson's, stroke and epilepsy.

This report analyzes AI adoption and use cases in neurology, highlighting geographic trends across North America, Europe, Asia-Pacific, South America and MEA. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, major company expenditures and venture capital funding in AI-driven neurology technologies.

The report examines the environmental, social and corporate governance (ESG) aspects influencing the adoption and ethical use of AI in neurology, reviews recent patent filings and innovation trends that reflect technological advancements in AI-based neuroimaging, brain-computer interfaces, digital therapeutics and wearable neurological devices.

A comprehensive competitive landscape analysis ranks and evaluates the market share of major players globally, highlighting their strategic initiatives, R&D investments and technological strengths in AI neurology solutions. The report concludes with detailed company profiles of key market participants, offering insights into their product portfolios, partnerships, acquisitions and contributions to the advancement of AI in neurological healthcare.

Report Includes

• 52 data tables and 69 additional tables
• An overview of the global market for AI in neurology
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and projected CAGRs through 2030
• Evaluation of the current market size and revenue growth prospects specific to AI in neurology, accompanied by a market share analysis by product type, application, end-user industry and region
• Analysis of current and future demand in the global neurology market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key market participants in the neurology market, along with their research priorities, product portfolios, global rankings and competitive landscape
• Company profiles of major players within the industry, including Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Nvidia Corp., and Canon Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• AI-Driven Personalization in Neurology: Advancing Prognosis, Treatment and Outcomes
• Porter's Five Forces Analysis
• Competitive Rivalry (High)
• Threat of New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Low to Moderate)
• Conclusion
• Macro-Economic Factor Analysis
• Economic Growth and Healthcare Spending
• Technological Advancement and R&D Investment
• Regulatory Environment and Policy Support
• Demographic Trends and Disease Burden
• Labor Market and Talent Availability

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rising Prevalence of Neurological Disorders
• Demand for Early Diagnosis and Precision Medicine
• Advancements in Neuroimaging and Data Analytics
• Support from Governments and Regulatory Agencies
• Market Restraints
• Neurological Workforce Paucity in Rural Areas and LMICs
• High Cost of AI Integration
• Market Opportunities
• Future Opportunities for AI in Neurology: Revolutionizing Diagnostics
• AI in Personalized Neurological Treatment Plans
• Market Challenges
• Lack of Standardized Validation and Transparency in AI-Based Neurology Tools
• Data Fragmentation Across Neurological Care Systems

Chapter 4 Regulatory Landscape

• Regulatory Scenario
• Regulatory Landscape in the U.S. for AI in Neurology: Devices
• Regulatory Landscape in the U.S. for AI in Neurology: AI/ML tools in Drugs and Biologics
• Regulatory Landscape in Europe for AI in Neurology
• Regulatory Landscape in Japan for AI in Neurology
• Regulatory Landscape in India for AI in Neurology

Chapter 5 Emerging Technologies and Patent Analysis

• Key Takeaways
• Generative AI in Neurology: Advancing Clinical Support and Knowledge Performance
• AI for Nuclear Neuroimaging in Neurology
• Integrating AI-Enhanced Brain-Computer Interfaces with Traditional and Complementary Neurology
• AI Tools for Cognitive and Mental Health in Neurology
• Emerging Role of LLMs and NLP in Neurology AI Applications
• Emerging Trends in AI for Neurology
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Key Takeaways
• AI in Neuro-Oncology and Neuroinflammatory Disorders
• AI in Neurovascular and Traumatic Brain Injury
• AI in Epilepsy and Functional Brain Disorders
• AI in Spinal and Movement Disorders
• AI in Neurodevelopmental and Psychiatric Conditions
• Market Breakdown by Application
• Key Takeaways
• Neuro Imaging Analysis
• Electroencephalography (EEG) Interpretation
• Clinical Decision Support
• Drug Discovery and Development
• Others
• Market Breakdown by Technology
• Key Takeaways
• Machine Learning and Deep Learning
• Natural Language Processing (NLP)
• Others
• Market Breakdown, by End User
• Key Takeaways
• Hospitals and Clinics
• Diagnostics Centers
• Research and Development Centers
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Company Share Analysis
• Key Developments and Strategies
• Partnerships and Collaborations
• Acquisition
• Business Expansions
• Product Launches, Approval

Chapter 8 Environmental, Social and Governance (ESG) Perspective

• Introduction to ESG
• The Role of AI in Neurology for Advancing Sustainability and Investment Impact
• ESG Sustainability in AI for Neurology: Efforts, by Major Players
• ESG Risk Ratings
• Concluding Remarks from BCC

Chapter 9 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• ACTIV SURGICAL
• AIRAMED GMBH
• BRAINOMIX
• BRAINQ TECHNOLOGIES LTD.
• CANON INC.
• GE HEALTHCARE
• KONINKLIJKE PHILIPS N.V.
• MEDTRONIC
• NEOSOMA INC.
• NEURALINK
• NEUROX
• NVIDIA CORP.
• QURE.AI
• SIEMENS HEALTHINEERS AG
• VIZ.AI INC.
• Few Emerging Start-ups/Market Disruptors